Cannabinoid CBG reduced anxiety and stress in first human clinical trial
On Jul. 31, 2024, researchers at Washington State University (WSU) announced that the cannabigerol (CBG) effectively reduced anxiety…
Biotechnology | Diagnostics | Disease | Life Science News | Medicine | Oncology | Therapeutics | Women's Health
Generation X and Millennials in U.S. Have Higher Risk of Developing 17 Cancers Compared to Older Generations
On Jul. 31, 2024, a large study led by researchers at the American Cancer Society (ACS) suggested incidence…
largest population-based study to date supported the survival benefits of immunotherapy for people with metastatic non-small cell lung cancer
On Jul. 29, 2024, a team led by the Barbara Ann Karmanos Cancer Institute and the Wayne State…
Biotechnology | CDC | Diagnostics | Genomics | Infectious Disease | Life Science News | Therapeutics
Maryland Department of Health issued consumer advisory for Boar’s Head liverwurst and other deli meat products due to possible Listeria contamination
On Jul. 26, 2024, the Maryland Department of Health advised consumers not to eat certain deli meats produced…
Boar’s Head Recalls Ready-To-Eat Liverwurst And Other Deli Meat Products Due to Possible Listeria Contamination
On Jul. 26. 2024, Boar’s Head, a Jarratt, Va., establishment, announced it was recalling all liverwurst product produced…
European Commission Approved Pfizer’s DURVEQTIX® (fidanacogene elaparvovec), a One-Time Gene Therapy for Adults with Hemophilia B
On Jul. 25, 2024, Pfizer announced that the European Commission (EC) has granted conditional marketing authorization for DURVEQTIX®…
Biotechnology | Disease | Life Science News | Medical Device | Non-Profit Research | Organ Transplant | Therapeutics
Successful first-in-human implantation of the BiVACOR Total Artificial Heart by Baylor and THI doctors
On Jul. 25, 2024, doctors from the Texas Heart Institute (THI), BiVACOR®, Baylor St. Luke’s Medical Center and…
CIRM approved $8 million award for plasma cell disorder therapy, $27 million to boost collaboration among California researchers
On Jul. 25, 2024, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
Biotechnology | COVID-19 | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics
Paxlovid led to better outcomes in hospitalized COVID cohort than Veklury or both drugs
On Jul. 24, 2024, the University of Hong Kong released a study that showed hospitalized COVID-19 patients treated…
CDC reported Listeria Outbreak Linked to Meats Sliced at Delis
On Jul. 19, 2024, the Centers for Disease Control and Prevention (CDC) announced that it had begun an…
Supplements slow disease progression during late stage of “dry” age-related macular degeneration
On Jul. 16, 2024, researchers at the National Institutes of Health (NIH) reported they have found that taking…
“LEQEMBI®” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Hong Kong
In Jul. 10, 2024, Eisai and Biogen announced that the Department of Health in Hong Kong has approved…
Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD
On Jul. 3, 2024, Regeneron Pharmaceuticals and Sanofi announced that the European Commission (EC) has approved Dupixent® (dupilumab)…
Biotechnology | Disease | Life Science News | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | Vaccine
Emergent BioSolutions Awarded $250+ Million in Contract to Supply U.S. Government with Four Critical Medical Countermeasure Products
On Jul. 2, 2024, Emergent BioSolutions announced it had received more than $250 millionin contract modifications from the…
Disease | Therapeutics | WHO
WHO releases first-ever clinical treatment guideline for tobacco cessation in adults
On Jul. 2, 2024, the World Health Organization (WHO) recommended a comprehensive set of tobacco cessation interventions, including…
CIRM awarded $26 million to advance clinical research across cancer, heart conditions, and rare diseases
On Jun. 28, 2024, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
FDA Permited Marketing of First Point-of-Care Hepatitis C RNA Test
On Jun. 27, 2024, the U.S. Food and Drug Administration granted marketing authorization to Cepheid for the Xpert…
NIAID Discovery Leads to Novel Probiotic for Eczema
On Jun. 26, 2024, National Institute of Allergy and Infectious Diseases (NIAID) announced that research has led to…
Biotechnology | Diagnostics | Disease | Life Science News | Oncology | Therapeutics | WHO
Nearly 1.8 billion adults at risk of disease from not doing enough physical activity
On Jun. 26. 2024, the World Health Organization reported that new data show that nearly one third (31%)…
CDC Updated RSV Vaccination Recommendation for Adults
On Jun. 26, 2024, the U.S. Centers for Disease Control and Prevention (CDC) updated its recommendation for the…
Biotechnology | Influenza | Life Science News | Therapeutics | USDA | Vaccine | Veterinary
USDA Approved Merck Animal Health’s NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine Influenza
On Jun. 25, 2024, Merck Animal Health announced U.S. Department of Agriculture (USDA) approval of NOBIVAC® NXT Canine…
Just – Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program
On Jun. 25, 2024, Evotec announced that its Seattle-based subsidiary, Just – Evotec Biologics, was selected by the…
CDC issued alert for increased risk of Dengue Virus infections in the U.S.
On Jun. 25, 2024 the Centers for Disease Control and Prevention (CDC) issued a Health Alert Network (HAN)…
Biotechnology | Disease | FDA | Life Science News | Medicine | Therapeutics
FDA Expanded Approval of Gene Therapy for Patients with Duchenne Muscular Dystrophy
On Jun. 20, 2024, the U.S. Food and Drug Administration expanded the approval of Sarepta Therapeutics’ Elevidys (delandistrogene…
Agriculture | Biotechnology | Chemical | Diagnostics | Environmental | EPA | Life Science News | Therapeutics
Air pollution accounted for 8.1 million deaths globally in 2021, Becoming the second leading risk factor for death
On Jun. 19, 2024, the Institute for Health Metrics and Evaluation (IHME) released a comprehensive new report that…
U.S. FDA Approved CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults
On Jun. 17, 2024, Merck announced that the U.S. Food and Drug Administration (FDA) had approved CAPVAXIVE™ (Pneumococcal…
COVID-19 | FDA | Life Science News | Therapeutics | Vaccine
FDA updated COVID-19 Vaccines for Use in the U.S Beginning in Fall 2024
On Jun. 14, 2024, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously voted to recommend…
Agriculture | Artificial Intelligence | Biology | Biotechnology | CMO | CRO | Life Science News | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
BioMADE to Establish Bioindustrial Manufacturing Infrastructure in Minnesota
On Jun. 13, 2024, BioMADE announced an investment in a state-of-the-art bioindustrial manufacturing infrastructure in Minnesota, following support…
National Academies announced New Broad Definition of Long COVID
On Jun. 11, 2024, the National Academies of Sciences, Engineering, and Medicine released a new report that stated the…
Biotechnology | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics | Vaccine
$140 million for UBC-led research hub to accelerate drug development and biomanufacturing
On May 31, 2024, a national research coalition led by the University of British Columbia (UBC) announced a…